Kenya joins global trial of Oxford University’s COVID-19 vaccine
KENYA has joined the global clinical trial of Oxford University's vaccine candidate against the new coronavirus, the state medical research institute has announced. The vaccine candidate, known as ChAdOx1 nCoV-19, has been developed jointly with AstraZeneca and is being evaluated in four countries: Britain, South Africa, Brazil and now Kenya. "To ensure that Kenyans can benefit... if it proves to be successful, it is important to assess its performance among Kenyan volunteers," the Kenya Medical Research Institute (KEMRI) said in a statement. KEMRI has already vaccinated the first volunteers after receiving the receiving the required regulatory and ethical approvals, it…